Reply to the letter titled "Difficult to evaluate the effect of remimazolam"
J Anesth
.
2022 Aug;36(4):578.
doi: 10.1007/s00540-022-03076-1.
Epub 2022 May 12.
Authors
Nami Kakuta
1
,
Shiho Satomi
2
,
Yasuo M Tsutsumi
2
Affiliations
1
Department of Anesthesiology, Tokushima University, 3-18-15, Kuramoto, Tokushima, 770-8503, Japan. kakuta.nami@tokushima-u.ac.jp.
2
Department of Anesthesiology and Critical Care, Hiroshima University, Hiroshima, Japan.
PMID:
35554697
DOI:
10.1007/s00540-022-03076-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Benzodiazepines*
Midazolam*
Substances
Benzodiazepines
remimazolam
Midazolam